Dolutegravir and the universal antiretroviral regimen: good may be the enemy of perfect

Dolutegravir and the universal antiretroviral regimen: good may be the enemy of perfect

Bibliographic Details
Main Authors:	Reuben Granich, Somya Gupta
Format:	Article
Language:	English
Published:	Elsevier 2018-05-01
Series:	Journal of Virus Eradication
Online Access:	http://www.sciencedirect.com/science/article/pii/S2055664020303733

Similar Items

SERCAP: is the perfect the enemy of the good?
by: White, NJ, et al.
Published: (2021)

SERCAP: is the perfect the enemy of the good?
by: Nicholas J. White, et al.
Published: (2021-06-01)

The role of stavudine in the South African public sector antiretroviral programme: Should the perfect be the enemy of the good?
by: Robin Wood
Published: (2006-05-01)

Increasingly Sensitive Troponin Assays: Is Perfect the Enemy of Good?
by: Cian P. McCarthy, et al.
Published: (2020-12-01)

Dolutegravir: Virologic response and tolerability of initial antiretroviral regimens for adults living with HIV.
by: Analú Correa, et al.
Published: (2020-01-01)

Dolutegravir-Based Antiretroviral Regimens for HIV Liver Transplant Patients in Real-Life Settings
by: Dario Cattaneo, et al.
Published: (2020-03-01)

Progress towards the 90-90-90 target: review of status and methodology of reported National HIV Care Continua
by: Reuben Granich, et al.
Published: (2018-05-01)

Age-specific national HIV care continua in sub-Saharan Africa
by: Somya Gupta, et al.
Published: (2018-05-01)

When will sub-Saharan Africa adopt HIV treatment for all?
by: Somya Gupta, et al.
Published: (2016-08-01)

Which antiretroviral regimen is associated with higher adherence in Brazil? A comparison of single, multi, and dolutegravir-based regimens
by: Tarsilla Spezialli Cardoso, et al.

Translating pharmacogenomics into clinical decisions: do not let the perfect be the enemy of the good
by: Kristi Krebs, et al.
Published: (2019-08-01)

Pharmacovigilance of antiretroviral dolutegravir in the state of Paraná
by: Bárbara Thaís Poliselo de Sá, et al.
Published: (2022-01-01)

Efficacy of Dolutegravir versus Darunavir in Antiretroviral First-Line Regimens According to Resistance Mutations and Viral Subtype
by: Pierluigi Francesco Salvo, et al.
Published: (2023-03-01)

Adherence, Effectiveness and Safety of Dolutegravir Based Antiretroviral Regimens among HIV Infected Children and Adolescents in Tanzania
by: Ritah F. Mutagonda PhD, et al.
Published: (2022-06-01)

Suppression of HIV in the first 12 months of antiretroviral therapy: a comparative analysis of dolutegravir- and efavirenz-based regimens
by: Gabriella Jomara da Silva, et al.
Published: (2023-05-01)

Dolutegravir based antiretroviral therapy compared to other combined antiretroviral regimens for the treatment of HIV-infected naive patients: A systematic review and meta-analysis.
by: Mario Cruciani, et al.
Published: (2019-01-01)

National HIV Care Continua for Key Populations
by: Somya Gupta MA, et al.
Published: (2017-03-01)

Evaluation of urinary excretion of dolutegravir or emtricitabine/tenofovir/elvitegravir/cobicistat antiretroviral-based regimens using plasma and urine trough concentration
by: Jérémy Lourenco, et al.
Published: (2018-05-01)

Searching for a long-acting injectable formulation for the antiretroviral dolutegravir
by: Anderson Aparecido de Marchi, et al.
Published: (2019-12-01)

Experience of dolutegravir-based antiretroviral treatment and risks of diabetes mellitus
by: Agete Tadewos Hirigo, et al.
Published: (2022-02-01)

Virologic efficacy of tenofovir, lamivudine and dolutegravir as second-line antiretroviral therapy in adults failing a tenofovir-based first-line regimen
by: Keene, CM, et al.
Published: (2021)

Perfect as the enemy of good: tracing transmissions with low-sensitivity tests to mitigate SARS-CoV-2 outbreaks
by: Lee Kennedy-Shaffer, PhD, et al.
Published: (2021-05-01)

A Meta-Analysis of the Effect of Bacillus Calmette-Guérin Vaccination Against Bovine Tuberculosis: Is Perfect the Enemy of Good?
by: Sreenidhi Srinivasan, et al.
Published: (2021-02-01)

Neurocognitive improvement in HIV-positive patients treated with dolutegravir-based regimens
by: Janine Rodrigues, et al.
Published: (2023-09-01)

Commentary: In search of the ideal right ventricle-to-pulmonary artery conduit: Is perfect the enemy of good, or will it foster excellence?Central Message
by: Minoo N. Kavarana, MD
Published: (2020-12-01)

Corrigendum: A Meta-Analysis of the Effect of Bacillus Calmette-Guérin Vaccination Against Bovine Tuberculosis: Is Perfect the Enemy of Good?
by: Sreenidhi Srinivasan, et al.
Published: (2021-07-01)

Revisiting efavirenz in the era of dolutegravir: Low-dose efavirenz, a viable alternative capable of holding its own against dolutegravir-based regimens
by: Sumit Arora, et al.
Published: (2023-01-01)

Antiretroviral drugs efavirenz, dolutegravir and bictegravir dysregulate blood-brain barrier integrity and function
by: Chang Huang, et al.
Published: (2023-03-01)

Case report: Emergence of dolutegravir resistance in a patient on second-line antiretroviral therapy
by: Kairoonisha Mahomed, et al.
Published: (2020-07-01)

Note for the Media WHO/Bulletin May 2012: Mobile phones transforming HIV testing in Africa
by: Ben Jones, et al.

Modern antiretroviral regimens
by: A. V. Kravchenko
Published: (2016-12-01)

Preventing HIV transmission with antiretrovirals
by: Kevin M De Cock, et al.
Published: (2009-07-01)

Commentary: Good, but not perfect.
by: Clarke, M
Published: (2008)

Case study: New onset of neuropsychiatric symptoms following switching to a dolutegravir regimen
by: Ahmed Badat, et al.
Published: (2022-03-01)

Isotopic Radiolabeling of the Antiretroviral Drug [<sup>18</sup>F]Dolutegravir for Pharmacokinetic PET Imaging
by: Marion Tisseraud, et al.
Published: (2022-05-01)

Growth, weight gain and BMI in virally suppressed children on antiretroviral therapy with specific reference to dolutegravir
by: Erik Belfrage, et al.
Published: (2023-07-01)

Southern African HIV Clinicians Society Guidance on the use of dolutegravir in first-line antiretroviral therapy
by: Michelle A. Moorhouse, et al.
Published: (2018-10-01)

<title language="eng">Note for the Media WHO/Bulletin May 2012: Mobile phones transforming HIV testing in Africa
by: Ben Jones, et al.
Published: (2012-05-01)

Effect of cotrimoxazole on mortality in HIV-infected adults on antiretroviral therapy: a systematic review and meta-analysis
by: Amitabh B Suthar, et al.
Published: (2012-02-01)

Don't Let Perfect Be the Enemy of Good: A Proof of Concept for a Custom National Data Repository of Quality Measures for Free and Charitable Clinics
Published: (2022-09-01)